BlackRock Health Sciences Term Trust is a top pick for high-yield dividends in healthcare. Click here to find out why BMEZ ...

This raises an important question: Are these moves into overbought conditions a signal of potential exhaustion, suggesting ...

We provide more details on some of the top companies in the Nasdaq 100 index that are dragging the QQQ ETF this year.

While the stock rose 7% in 2024, that gain was split between a 318% rocket ride higher from where it ended 2023 (at $28.43) to its March 13 record close of $118.81, and the 74% plunge from there to ...

Amgen's first-in-class KRAS inhibitor Lumykras ... hailed by cancer charity Breast Cancer NOW, which has called on Gilead Sciences to agree a similar access deal with the NHS for its Trodelvy ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of ...

Gilead Sciences's GILD short percent of float has risen 6.47% since its last report. The company recently reported that it ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...